Stefan Peters;Elke Langkopf;Frank Himmelsbach;Matthias Eckhardt
发明人:
Frank Himmelsbach,Matthias Eckhardt,Elke Langkopf,Stefan Peters
申请号：
US13869144
公开号：
US08809376B2
申请日:
2013.04.24
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to compounds of general formula I,wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
